Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future Prospects Ilias GiarenisDudley RobinsonLinda Cardozo Current Opinion 01 September 2015 Pages: 1707 - 1713
Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia Matthew K. ItoGerald F. Watts Therapy in Practice Open access 14 September 2015 Pages: 1715 - 1724
Management of Hematologic Malignancies: Special Considerations in Pregnant Women Odelia AmitMerav BarzilaiIrit Avivi Therapy in Practice 28 September 2015 Pages: 1725 - 1738
Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2 Nele BoeckxMarc PeetersVanessa Deschoolmeester Review Article 07 September 2015 Pages: 1739 - 1756
Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results Alice PasiniAngelo DelmonteEmanuele Giordano Review Article 07 September 2015 Pages: 1757 - 1771
Ruxolitinib: A Review in Polycythaemia Vera Kate McKeage Adis Drug Evaluation 11 September 2015 Pages: 1773 - 1781
Saxagliptin: A Review in Type 2 Diabetes Sohita Dhillon Adis Drug Evaluation 24 September 2015 Pages: 1783 - 1796
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease Hannah A. BlairGillian M. Keating Adis Drug Evaluation 25 September 2015 Pages: 1797 - 1806
Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension Sheridan M. Hoy Adis Drug Evaluation 02 October 2015 Pages: 1807 - 1813
Flibanserin: First Global Approval Emma D. Deeks AdisInsight Report 28 September 2015 Pages: 1815 - 1822
Cobimetinib: First Global Approval Karly P. Garnock-Jones AdisInsight Report 09 October 2015 Pages: 1823 - 1830
Erratum to: Dinutuximab: First Global Approval Sohita Dhillon Erratum 13 October 2015 Pages: 1831 - 1831
